Louisiana State Employees Retirement System Reduces Stock Holdings in Teleflex Incorporated $TFX

Louisiana State Employees Retirement System lowered its position in Teleflex Incorporated (NYSE:TFX) by 5.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 20,600 shares of the medical technology company’s stock after selling 1,300 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Teleflex were worth $2,438,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Banque Cantonale Vaudoise purchased a new stake in shares of Teleflex in the first quarter valued at about $27,000. Costello Asset Management INC purchased a new stake in shares of Teleflex in the first quarter valued at about $28,000. Brooklyn Investment Group grew its holdings in shares of Teleflex by 258.6% in the first quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 150 shares during the period. Thurston Springer Miller Herd & Titak Inc. boosted its stake in Teleflex by 242.9% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock worth $26,000 after buying an additional 153 shares during the period. Finally, Allworth Financial LP boosted its stake in Teleflex by 504.8% during the first quarter. Allworth Financial LP now owns 254 shares of the medical technology company’s stock worth $34,000 after buying an additional 212 shares during the period. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have weighed in on TFX. Wall Street Zen lowered shares of Teleflex from a “strong-buy” rating to a “buy” rating in a research note on Monday, September 15th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Teleflex in a research note on Wednesday. Mizuho increased their target price on shares of Teleflex from $130.00 to $135.00 and gave the stock a “neutral” rating in a research note on Friday, August 1st. Zacks Research lowered shares of Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 30th. Finally, Royal Bank Of Canada increased their target price on shares of Teleflex from $130.00 to $135.00 and gave the stock a “sector perform” rating in a research note on Friday, August 1st. One analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and a consensus price target of $141.57.

Insider Buying and Selling at Teleflex

In other news, CEO Liam Kelly bought 1,500 shares of Teleflex stock in a transaction that occurred on Tuesday, August 5th. The shares were purchased at an average price of $115.07 per share, with a total value of $172,605.00. Following the completion of the acquisition, the chief executive officer directly owned 45,267 shares in the company, valued at $5,208,873.69. The trade was a 3.43% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gretchen R. Haggerty bought 500 shares of Teleflex stock in a transaction that occurred on Wednesday, August 6th. The stock was purchased at an average cost of $114.75 per share, for a total transaction of $57,375.00. Following the acquisition, the director owned 6,305 shares of the company’s stock, valued at $723,498.75. This represents a 8.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 5,500 shares of company stock valued at $633,590. Corporate insiders own 1.40% of the company’s stock.

Teleflex Stock Down 4.1%

Shares of TFX opened at $119.54 on Friday. The stock has a market capitalization of $5.28 billion, a PE ratio of 28.13, a P/E/G ratio of 1.74 and a beta of 1.05. Teleflex Incorporated has a 1 year low of $108.90 and a 1 year high of $241.41. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. The company’s 50-day simple moving average is $124.30 and its 200-day simple moving average is $124.29.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.36 by $0.37. The business had revenue of $780.90 million for the quarter, compared to analysts’ expectations of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The business’s quarterly revenue was up 4.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.42 earnings per share. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. Analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Friday, August 15th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend was Friday, August 15th. Teleflex’s dividend payout ratio is currently 32.00%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.